ArticleDrugs in context2025

Sustained disease control with pembrolizumab-lenvatinib in a patient with heavily pre-treated recurrent endometrial carcinoma: a case report.

Alessia Lancianese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.